Gene-Tailored Treatments for Brain Disorders: Challenges and Opportunities

Area of Science:

• Neuromedicine
• Genetics
• Personalized Medicine

Background:

• Brain disorders present complex challenges due to diverse etiologies.
• Current understanding of genetic and genomic pathways for brain disorders is limited.
• Neuromedicine faces hurdles in developing innovative treatments.

Purpose of the Study:

• To review challenges and advances in neuromedicine.
• To highlight the role of genetic and genomic understanding in brain disorder treatment.
• To discuss the potential of personalized medicine for brain disorders.

Main Methods:

• Review of current literature on brain disorder genetics and treatment.
• Analysis of genetic factors in specific disorders like Huntington's disease and brain tumors.
• Examination of genetic approaches for psychiatric disorders and treatment response prediction.

Main Results:

• Single gene mutations (e.g., Huntington's disease) enable targeted therapies.
• Genetic analysis aids individualized therapies for brain tumors.
• Psychiatric disorders like schizophrenia and depression lack single gene targets but benefit from predictive genetic information.
• Genetic insights can improve early diagnosis, treatment response prediction, and reduce adverse drug reactions.

Conclusions:

• Personalized medicine for brain disorders is promising but requires further research.
• Infrastructure adaptations, including legal and regulatory frameworks, are essential.
• Increased access to brain tissue samples through brain banking is crucial.
• Collaboration among stakeholders, including patients, is vital for progress.